Background. A number of molecular epidemiological studies have been conducted to explore the association of human papillomavirus (HPV) infection with laryngeal cancer. However, the findings are heterogeneous.
Cancer of the larynx accounts for >3% of all cancers, making it the sixth most common cancer worldwide [1] . In 2011, the number of laryngeal cancer-related deaths worldwide was estimated to be 3560 [1] . The potential oncogenic role of human papillomavirus (HPV) infection in the development of laryngeal cancer has been well recognized in recent decades [2] .
Since the early twentieth century, HPV has been suggested to be the source of laryngeal cancer morbidity [3] . As reported elsewhere, the frequency of HPV infection among laryngeal invasive lesions or carcinomas varies between 0% and 79% [4, 5] . At present, >100 different types of HPV have been identified [6] . Of these, about 15 types have been classified as "highrisk" types (HR-HPV), because of their oncogenic potential; however, "low-risk" types (LR-HPV) can also be found in several kinds of cancers. As in cervical carcinomas, HPV-16 seems to be the most common genotype, with nearly 34% of laryngeal cancers [7] and 11% of head and neck tumors [8] testing positive. However, the role of HR-HPV in the development of laryngeal cancer has not been clearly defined.
A previous meta-analysis based on a review of studies published until February 2004 suggested that HPV infection might increase the risk of laryngeal cancer, with a summary odds ratio (OR) of 2.0 (95% confidence interval [CI], 1.0-4.2) [9] . However, Hobbs et al [9] did not address the prevalence of HPV infection, and more-detailed analyses were restricted by the limited number of included studies. Since the 1990s, a number of studies have addressed HPV prevalence in various histological types of laryngeal cancers, mainly squamous cell carcinomas (SCCs). However, a recent review concluded that the relationship between HPV infection and laryngeal cancer is unclear [10] , and different anatomic sites or different populations might harbor different HPV genotypes.
Evidence provided by the published literature makes it possible to establish a relationship between laryngeal cancers and HPV genotypes. Therefore, the present study explores the prevalence of HPV in laryngeal cancer tissues and the association between HPV infection and laryngeal cancer risk by means of systematic review and meta-analysis.
METHODS

Literature Search
PubMed (from 1946 onward), MEDLINE (from 1947 onward), and EMBASE (from 1974 onward) were searched to obtain articles published up to 15 May 2012 that addressed HPV and laryngeal cancer. Combinations of the key words "papillomavirus," "human," "laryngeal cancer," and "larynx carcinoma" were used for the literature search.
Eligibility Criteria
The criteria for inclusion in the meta-analyses were as follows: (1) observational studies detected HPV DNA in laryngeal cancer tissues, (2) information on the HPV DNA detection method was explicitly provided, (3) articles were published in English, (4) necessary data could be directly extracted or calculated from the original article (if the study was reported in duplication, the article that was published earlier or that provided more-detailed information was included), and (5) HPV DNA could be evaluated by polymerase chain reaction (PCR)-based methods (using broad-spectrum PCR primers, type-specific PCR primers, or a combination of both kinds of primers), as well as non-PCR methods.
We excluded review articles, case reports, studies in languages other than English, and patients with secondary malignant tumors of the larynx. To minimize the potential bias caused by small sample sizes, articles with <20 patients were excluded.
Data Extraction
All potentially relevant literatures were reviewed independently by 2 investigators, and consensus was reached on all items. For each included study, the following information was extracted: first author and year of publication, study population and enrollment time, major demographic characteristics (ie, age and sex) of the study participants, sample size, specimen type, HPV DNA source and detection method, and number of specimens positive for specific HPV types.
Statistical Analysis
The summary prevalence of HPV infection in laryngeal cancer was determined using a random-effects model developed by Comprehensive Meta-Analysis (V2.0, Biostat, Englewood, NJ). The association between HPV infection and laryngeal cancer risk was estimated by means of ORs and corresponding 95% CIs generated by comparisons of cases with controls. Stratified analyses were subsequently performed with respect to the characteristics of the study population (histological type and grade, location, and clinical stage of the cancer and geographic area of the study) and study methods (HPV DNA specimen and detection method). Heterogeneity between included studies was assessed by the I 2 and Q tests (P < .05 was considered indicative of statistically significant publication bias) [2] . Publication bias was assessed with Begg rank correlation [11] and Egger weighted regression methods [12] . Differences between the stratified analyses were assessed by χ 2 tests. 
RESULTS
As shown in Figure 1 , 1622 articles were identified by database searches with different combinations of key words. The abstracts of 912 articles were reviewed, and 820 were excluded because they did not satisfy eligibility criteria. Finally, 53 articles (55 studies) addressing the prevalence of HPV in laryngeal cancer were identified and included in this study ( The prevalence of HR-HPV types (26.6% of cases) was found to be much higher than that of LR-HPV types (3.7%). The most common HPV type was HPV-16, with a summary prevalence of 19.8% (95% CI, 15.7%-24.6%). The remaining most frequently identified HPV types were HPV-18 (6.2% of cases; 95% CI, 4.0%-9.5%), HPV-33 (3.3%; 95% CI, 2.1%-5.1%), HPV-31 (2.4%; 95% CI, 1.3%-4.4%), HPV-6 (4.3%; 95% CI, 2.4%-7.7%), and HPV-11 (2.3%; 95% CI, 1.2%-4.4%).
Seventeen studies provided detailed data on the prevalence of HPV, by sex of the patient and the histological type and location of the cancer (Supplementary Table 2 ). Table 4 shows results of analyses stratified with respect to these factors. The HPV prevalence was found to be significantly higher in South America (35.6%; 95% CI, 26.1%-46.3%; P = .00), compared with Asia (25.6%, 95% CI, 15.9%-38.5%), North America (26.4%; 95% CI, 14.8%-42.6%), and Europe (26.8%; 95% CI, 20.5%-34.2%). HPV DNA was detected in 31.9% of males (95% CI, 24.0%-41.0%) and 35.2% of females (95% CI, 26.5%-45.1%). The HPV prevalence did not differ significantly on the basis of whether HPV DNA was extracted from fixed tissue samples (29.0%; 95% CI, 23.3%-35.5%) or fresh tissue samples (27.7%; 95% CI, 20.7%-36.1%; P = .092). Analyses stratified by cancer location showed that laryngeal cancers in the glottis region had the highest HPV prevalence (35.2%; 95% CI, 28.2%-42.8%), followed by those in the supraglottic region (30.5%; 95% CI, 24.0%-37.8%) and the subglottic region (27.5%; 95% CI, 17.5%-4.04%). With respect to HPV DNA detection methods, the estimate determined by PCRbased methods (29.5%; 95% CI, 24.5%-35.0%) was observed to be higher than that determined by non-PCR methods (20.4%; 95% CI, 11.8%-32.9%; P < .01).
To estimate the association between HPV infection and the risk of laryngeal cancer, 12 case-control studies providing necessary data were included in the meta-analysis; 638 patients and 419 controls were enrolled (Supplementary Table 3) . Most of the studies collected control specimens from normal laryngeal mucosa of the laryngeal cancer patients, but 1 study from collected control specimens from cadavers [13] . As shown in Table 5 , an OR of 5.39 (95% CI, 3.25-8.94) was detected, suggesting that HPV infection was associated with a significantly increased risk of laryngeal SCC; this odds ratio is higher than that for breast cancer (OR, 3.63; 95% CI, 1.42-9.27) [14] , oropharyngeal cancer (OR, 4.3; 95% CI, 2.1-8.9), and oral cancer (OR, 2.0; 95% CI, 1.2-3.4) [9] . When the analysis was restricted to HR-HPV, the association was 5.74 (95% CI, 3.05-10.80). The ORs of individual types indicated differences in the magnitudes of the association for HPV-16 (6.07; 95% CI, 3.44-10.70) and HPV-18 (4.16; 95% CI, .87-20.04; P = .00). For HPV-6 and HPV-11, the summary ORs were not statistically significant (data not shown). Detection of HPV DNA in fixed tissue showed a significant higher association as compared to detection in fresh tissue, with ORs of 8.43 (95% CI, 4.03-17.61) and 3.23 (95% CI, 1.69-6.18), respectively (P = .01).
No evident publication bias was observed in both metaanalyses of the association between HPV prevalence and laryngeal cancer risk (P > .05), according to Begg rank correlation analysis and Egger weighted regression analysis.
DISCUSSION
In this meta-analysis addressing HPV prevalence and its association with laryngeal cancer, 55 studies were included and summarized. The overall HPV prevalence in laryngeal cancer was found to be 28.0% (95% CI, 23.5%-32.9%). HPV-16 was the most frequently observed subtype, with a prevalence of 19.8% (95% CI, 15.7%-24.6%). A significant association was found between HPV infection and laryngeal SCC risk, with a summary OR of 5.39 (95% CI, 3.25-8.94).
HPV infection has been suggested to play an important role in both benign and malignant pathologies of the larynx [15] . Our results indicate that the association between HPV infection and laryngeal cancer risk is strong, with an OR of 5.39 (95% CI, 3.32-8.73) that is higher than that for breast cancer (OR, 3.63; 95% CI, 1.42-9.27) [14] , oropharyngeal cancer (OR, 4.3; 95% CI, 2.1-8.9), and oral cancer (OR, 2.0; 95% CI, 1.2-3.4) [9] . The relationship between HPV infection and laryngeal cancer was assessed by a meta-analysis published in 2006 [9] . However, the results of that study (OR, 2.0; 95% CI, 1.0-4.2) were obscure because the meta-analysis included relatively few publications (8 studies). Published studies have indicated that HPV is epithelium tropic [16] and might cause cancers in multiple sites. However, the previous meta-analysis included 3 studies in which HPV was detected only in plasma and serum specimens, not in cancer tissues [9] . Moreover, this meta-analysis did not assess the prevalence of HPV infection in the laryngeal cancer. Our meta-analysis not only estimated the relationship between HPV infection and laryngeal cancer risk on the basis of much more recently published data, it also provided a summary of HPV prevalence among cases of laryngeal cancer. The estimated HPV prevalence among cancers might vary with respect to the study population, HPV detection methods, and cancer characteristics. In our study, factors that might cause heterogeneity between studies were considered in stratified analyses. Overall, the summary prevalence of HPV infection in laryngeal cancer (28.0%; 95% CI, 23.5%-32.9%) was found to be lower than that of oral SCC (34.5%; 95% CI, 28.4%-40.6%) [17] and cervical SCC (86.9%; 95% CI, 84.8%-89.5%) [18] . When the analyses were stratified by HPV type, the prevalence of HR-HPV was higher than that of LR-HPV and therefore was associated with a higher risk of laryngeal cancer. Various HPV prevalences in laryngeal cancers were observed in different geographical regions (range, 25.6%-35.6%). Studies from South America reported a higher rate of HPV infection, which might be explained by differences in genetic backgrounds, ethnic and cultural differences, and other, unknown, factors. Geographical variation of the prevalence of HPV in other cancers has also been observed. Worldwide, the prevalence of cervical HPV infection is higher in Africa and East Asia and lower in North America and Europe [19] . Analysis stratified by tumor location showed that the HPV prevalence among cancers of the glottis was higher as compared to the prevalence at other locations. The microenvironment of the glottis might favor HPV infection, because the squamocolumnar junction in the ventricle is similar to the cervical transformation zone. HPV types targeted for detection might differ because of variations in the study design and in the sensitivity and specificity of the detection methods. We observed that the estimate based on PCR-based studies was higher than that based on non-PCR-based studies, which suggests that PCR methods might be more sensitive than non-PCR methods. This finding is consistent with reports that used both PCR and non-PCR methods in the same study [20] . Differences in consensus primers (ie, MY09-11 and GP5+/GP6+) used for detection might be another potential reason for heterogeneity between studies. However, corresponding stratified analyses were restricted by the limited number of studies that provided necessary information. It is well-known that significant DNA degradation might occur in paraffin-embedded tissue [21] . However, our results did not find statistically significant differences in HPV DNA positivity between studies that used fixed specimens and those that used fresh frozen specimens. Overall, in future studies, standardized laboratory methods are needed to improve the generalizability of HPV prevalence data and the estimate of the influence of HPV infection on cancer development. It is necessary to consider the limitations of the present meta-analysis while interpreting the results. First, potential bias could not be excluded completely because estimates of HPV infection largely depend on the sensitivity and accuracy of the HPV DNA detection method and the HPV types targeted by the method. Second, potential language bias might exist because our literature search only considered articles published in English. Third, evident heterogeneity was observed between the included studies. As suggested by our subgroup analyses, this heterogeneity might be explained, at least in part, by variations in study populations and study designs (eg, patient characteristics and HPV DNA detection methods, respectively). Fourth, the crude division of study population by geographic regions makes the analyses prone to misclassification bias. Further studies providing detailed information on different populations are warranted to verify current findings.
In conclusion, our meta-analysis suggested a significantly increased risk of SCC associated with HPV infection. HPV-16 was the most frequently observed subtype in laryngeal cancer specimens and showed a strong association with the development of cancer. However, the association between HPV infection and laryngeal cancer risk was not substantially influenced by factors that might influence HPV prevalence, such as geographic region, clinical stage and location of the cancer, and HPV DNA detection methods. Further studies are needed to verify the relationship between HPV infection and laryngeal cancer and to explore the underlying mechanisms of their association.
Supplementary Data
Supplementary materials are available at The Journal of Infectious Diseases online (http://jid.oxfordjournals.org/). Supplementary materials consist of data provided by the author that are published to benefit the reader. The posted materials are not copyedited. The contents of all supplementary data are the sole responsibility of the authors. Questions or messages regarding errors should be addressed to the author. 
Notes
